The Impact of COVID-19 is included in Inhaled Nitric Oxide Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Inhaled Nitric Oxide Trends and Forecast
The future of the global inhaled nitric oxide market looks promising with opportunities in the neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, and tuberculosis treatment markets. The global inhaled nitric oxide market is expected to reach an estimated $1.1 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of respiratory and other associated diseases along with ongoing research and development activities.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Inhaled Nitric Oxide by Segment
The study includes a forecast for the global inhaled nitric oxide by product type, application, and region.
Inhaled Nitric Oxide Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
• Gas
• Delivery Systems
Inhaled Nitric Oxide Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Neonatal Respiratory Treatment
• Asthma and COPD
• Acute Respiratory Distress Syndrome
• Malaria Treatment
• Tuberculosis Treatment
• Others
Inhaled Nitric Oxide Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Inhaled Nitric Oxide Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies inhaled nitric oxide companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the inhaled nitric oxide companies profiled in this report include-
• Air Liquide Healthcare
• BOC Healthcare
• Matheson Tri-Gas
• Merck
• Mallinckrodt Pharmaceuticals
• Nu-Med Plus
• Perma Pure
Inhaled Nitric Oxide Market Insights
Lucintel forecasts that delivery systems is expected to witness the higher growth over the forecast period due to introduction of compact and portable delivery system, which enables for easier administration of nitric oxide therapy in various healthcare applications.
Within this market, asthma and COPD is expected to witness the highest growth due growing consumption of cigarettes, which contributes to asthma and COPD symptoms.
North America is expected to witness highest growth over the forecast period due to surging incidence of diseases like COPD and asthma, increasing aging population, and presence of major palyers in the region.
Features of the Global Inhaled Nitric Oxide Market
Market Size Estimates: Inhaled nitric oxide market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Inhaled nitric oxide market size by product type, application, and region in terms of value ($B).
Regional Analysis: Inhaled nitric oxide market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the inhaled nitric oxide market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the inhaled nitric oxide market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the inhaled nitric oxide market size?
Answer: The global inhaled nitric oxide market is expected to reach an estimated $1.1 billion by 2030.
Q2. What is the growth forecast for inhaled nitric oxide market?
Answer: The global inhaled nitric oxide market is expected to grow with a CAGR of 5.1% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the inhaled nitric oxide market?
Answer: The major drivers for this market are increasing prevalence of respiratory and other associated diseases along with ongoing research and development activities.
Q4. What are the major segments for inhaled nitric oxide market?
Answer: The future of the inhaled nitric oxide market looks promising with opportunities in the neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, and tuberculosis treatment markets.
Q5. Who are the key inhaled nitric oxide market companies?
Answer: Some of the key inhaled nitric oxide companies are as follows:
• Air Liquide Healthcare
• BOC Healthcare
• Matheson Tri-Gas
• Merck
• Mallinckrodt Pharmaceuticals
• Nu-Med Plus
• Perma Pure
Q6. Which inhaled nitric oxide market segment will be the largest in future?
Answer: Lucintel forecasts that delivery systems is expected to witness the higher growth over the forecast period due to introduction of compact and portable delivery system, which enables for easier administration of nitric oxide therapy in various healthcare applications.
Q7. In inhaled nitric oxide market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to surging incidence of diseases like COPD and asthma, increasing aging population, and presence of major palyers in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the inhaled nitric oxide market by product type (gas and delivery systems), application (neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, tuberculosis treatment, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Inhaled Nitric Oxide Market, Inhaled Nitric Oxide Market Size, Inhaled Nitric Oxide Market Growth, Inhaled Nitric Oxide Market Analysis, Inhaled Nitric Oxide Market Report, Inhaled Nitric Oxide Market Share, Inhaled Nitric Oxide Market Trends, Inhaled Nitric Oxide Market Forecast, Inhaled Nitric Oxide Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Inhaled Nitric Oxide Market: Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Inhaled Nitric Oxide Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Inhaled Nitric Oxide Market by Product Type
3.3.1: Gas
3.3.2: Delivery Systems
3.4: Global Inhaled Nitric Oxide Market by Application
3.4.1: Neonatal Respiratory Treatment
3.4.2: Asthma and COPD
3.4.3: Acute Respiratory Distress Syndrome
3.4.4: Malaria Treatment
3.4.5: Tuberculosis Treatment
3.4.6: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Inhaled Nitric Oxide Market by Region
4.2: North American Inhaled Nitric Oxide Market
4.2.2: North American Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
4.3: European Inhaled Nitric Oxide Market
4.3.1: European Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
4.3.2: European Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
4.4: APAC Inhaled Nitric Oxide Market
4.4.1: APAC Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
4.4.2: APAC Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
4.5: ROW Inhaled Nitric Oxide Market
4.5.1: ROW Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
4.5.2: ROW Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Product Type
6.1.2: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Application
6.1.3: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Region
6.2: Emerging Trends in the Global Inhaled Nitric Oxide Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Inhaled Nitric Oxide Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Inhaled Nitric Oxide Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Air Liquide Healthcare
7.2: BOC Healthcare
7.3: Matheson Tri-Gas
7.4: Merck
7.5: Mallinckrodt Pharmaceuticals
7.6: Nu-Med Plus
7.7: Perma Pure
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Inhaled Nitric Oxide Market Report.